Back
Vertex Pharmaceuticals 10K Form
Buy
64
VRTX
Vertex Pharmaceuticals
Last Price:
417.44
Seasonality Move:
12.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-07 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
2023-08-02 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
2023-05-02 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
2023-02-10 | 10K | VRTX/Vertex Pharmaceuticals Annual |
2022-10-28 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
2022-08-05 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
Receive VRTX News And Ratings
See the #1 stock for the next 7 days that we like better than VRTX
VRTX Financial Statistics
Sales & Book Value
Annual Sales: | $9.87B |
---|---|
Cash Flow: | $118.5M |
Price / Cash Flow: | 33.17 |
Annual Sales: | $68.22 |
Price / Book: | 6.13 |
Profitability
EPS (TTM): | 13.89000 |
---|---|
Net Income (TTM): | $3.62B |
Gross Margin: | $8.61B |
Return on Equity: | 23.23% |
Return on Assets: | 17.76% |
Vertex Pharmaceuticals Earnings Forecast
Key Vertex Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 33 years for VRTX is 87.21%.
- The Selling, General & Administrative Expenses for VRTX have been equal to 11.52% of Gross Profit Margin.
- The Research & Development expenses have been 32.05% of Revenue.
- The Interest Expense is 1.22% of Operating Income.
- The Net Earning history of VRTX is 36.68% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 14 years.
Vertex Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | VRTX |
CUSIP: | 92532F |
Website: | vrtx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.99 |
Quick Ratio: | 3.6 |
Price-to-Earnings
Trailing P/E Ratio: | 30.06 |
---|---|
Forward P/E Ratio: | 22.73 |
VRTX Technical Analysis vs Fundamental Analysis
Buy
64
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $417.50. The Score for VRTX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.